Cyclo-oxygenase 2 and breast cancer prevention

被引：21

作者：

Vainio, H ^{[1
]}

机构：

[1] Int Agcy Res Canc, Unit Chemoprevent, F-69372 Lyon 08, France

来源：

BRITISH MEDICAL JOURNAL | 1998年 / 317卷 / 7162期

关键词：

D O I：

10.1136/bmj.317.7162.828

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：828 / 828

页数：1

共 10 条

[1] Prospective study of regular aspirin use and the risk of breast cancer [J].

Egan, KM ;

Stampfer, MJ ;

Giovannucci, E ;

Rosner, BA ;

Colditz, GA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (14) :988-993

[2]

Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97

[3] Meloxicam: Selective COX-2 inhibition in clinical practice [J].

Furst, DE .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 26 (06) :21-27

[4] Nonsteroidal antiinflammatory drugs and breast cancer [J].

Harris, RE ;

Namboodiri, KK ;

Farrar, WB .

EPIDEMIOLOGY, 1996, 7 (02) :203-205

[5]

*IARC, 1977, IARC HDB CANC PREV, V1, P1

[6]

Liu XH, 1996, CANCER RES, V56, P5125

[7]

Parrett ML, 1997, INT J ONCOL, V10, P503

[8]

Ristimaki A, 1997, CANCER RES, V57, P1276

[9] PROSTAGLANDIN E(2) PRODUCTION AND METABOLISM IN HUMAN BREAST-CANCER CELLS AND BREAST FIBROBLASTS - REGULATION BY INFLAMMATORY MEDIATORS [J].

SCHREY, MP ;

PATEL, KV .

BRITISH JOURNAL OF CANCER, 1995, 72 (06) :1412-1419

[10] INHIBITION OF PROSTAGLANDIN SYNTHESIS AS A MECHANISM OF ACTION FOR ASPIRIN-LIKE DRUGS [J].

VANE, JR .

NATURE-NEW BIOLOGY, 1971, 231 (25) :232-&

← 1 →